Search

Author/Creator Barry, Evan

1. A pharmacokinetic–pharmacodynamic model for the MET tyrosine kinase inhibitor, savolitinib, to explore target inhibition requirements for anti‐tumour activity. (7th December 2020)

Authors:
Jones, Rhys D.O.; Grondine, Mike; Borodovsky, Alexandra; San Martin, Maryann; DuPont, Michelle; D'Cruz, Celina; Schuller, Alwin; Henry, Ryan; Barry, Evan; Castriotta, Lillian; Anjum, Rana; Petersson, Klas; Sahota, Tarjinder; Ahmed, Ghada F.
Journal:
British journal of pharmacology
Issue:
Volume 178:Number 3(2021)
Page Start:
600
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation. Issue 2 (22nd December 2016)

Authors:
Myant, Kevin B; Cammareri, Patrizia; Hodder, Michael C; Wills, Jimi; Von Kriegsheim, Alex; Győrffy, Balázs; Rashid, Mamun; Polo, Simona; Maspero, Elena; Vaughan, Lynsey; Gurung, Basanta; Barry, Evan; Malliri, Angeliki; Camargo, Fernando; Adams, David J; Iavarone, Antonio; Lasorella, Anna; Sansom,...
Journal:
EMBO molecular medicine
Issue:
Volume 9:Issue 2(2017)
Page Start:
181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search